Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 551 for “"Gliomas"”.
-
Characterisation of cytokine secretion in malignant gliomas
Cytokines are proteins produced by cells of the immune system. The working hypothesis of the thesis is to show that the lymphocytes and glial cells in Glioblastoma Multiformae patients have an altered pattern of secretion of cytokines compared with low-grade and non-cancerous patients. Lymphocyte …
-
Factores pronósticos en gliomas de alto grado
Los gliomas de alto grado son la tumoración cerebral maligna primaria más frecuente en adultos. Debido al envejecimiento de la población, el diagnóstico en las personas de edad avanzada es cada vez más frecuente y, a pesar de los tratamientos estandarizados, existen diferencias en supervivencia …
-
Gene and Protein Expression in Human Gliomas
The human gliomas are the most common primary brain tumours. They are highly aggressive with a rapid fatal progression for the patient. The invasive growth pattern and inherent resistance to radiation and chemotherapy account for a lack of efficient therapies. Several novel therapeutic regimes are …
-
H19: a potential therapeutic target in gliomas
Gliomas are aggressive glial cell tumors that are nearly impossible to treat successfully, yielding strikingly low survival rates for patients. Glioblastomas, the most severe type of gliomas, have even poorer prognoses. In the past decade, new literature has shown that H19, a long non-coding RNA …
-
Exploring molecular links between gliomas and Alzheimer’s Disease
SORL1 loss is a known risk factor for Alzheimer's disease (AD) while SORL1 overexpression is seen in various cancers. Consequently, an inverse correlation between AD and cancer has been established. As SORL1 loss in AD has a clearly defined molecular role in the formation of amyloid plaques, a …
-
Cell proliferation, cell death, and differentiation in gliomas
<p>Gliomas including the commonest primary brain tumour, the glioblastoma, are incurable; any therapeutic advances will depend on an increased understanding of their biology. Gliomas are currently classified on the basis of histology, but analysis of regulators and markers of cell proliferation and …
-
FLUORESCEIN-GUIDED SURGERY FOR RESECTION OF MALIGNANT GLIOMAS
… for intraoperative visualization of high-grade gliomas (HGG). This study presents a new fluorescein-guided technique to remove HGG with a dedicated filter on the surgical microscope (FLUOGLIO trial). Methods: The FLUOGLIO study is a prospective phase II-trial to evaluate safety and obtain …
-
Molecular Consequences of High Taz Expression In Gliomas
Diffuse high grade gliomas are complex and lethal neoplasms of the adult central nervous system that are driven by a range of genetic and epigenetic alterations. Molecular classification of these tumors has identified different transcriptional subtypes, the most notable being Proneural (PN) and …
-
Monocarboxylate Transporters in gliomas: regulation and therapeutic implications
Glioblastoma (GBMs) is the brain tumour with the highest prevalence and lethality. Besides the progress in therapy, the overall survival is still 15 months and patients have a worse prognosis. Thus, it is important to identify new molecular therapeutic targets that could improve the quality of life …
-
Molecular Pathways to Initiation and Progression in Gliomas
Gliomas are the most common primary adult brain tumors. Despite current treatment, including surgery radio- and chemotherapy, these tumors continue to progress and recur with a more aggressive and resistant phenotype. Recurrence is believed to be, in no small part, due to the presence within the …
-
Sulfatides-containing liposomes as novel nano carriers targeting gliomas
Malignant gliomas represent a difficult therapeutic challenge due to the invasive nature of the tumor and limited tumoral delivery of therapeutic agents. In this study, novel nano liposome carriers composed of sulfatides were developed for the glioma targeted delivery. Firstly, …
-
Deciphering and Targeting ALK- and ROS1-Driven Pediatric Gliomas
… profiling to enhance diagnostic precision. Gliomas, the most prevalent central nervous system (CNS) tumors across all age groups, are now divided into pediatric-type and adult-type gliomas, reflecting distinct biological and clinical differences. Within pediatric-type high-grade gliomas …
-
Hypoxia in gliomas: a pathogenic driver and therapeutic opportunity
Gliomas are highly malignant brain tumours characterised by extensive areas of hypoxia which significantly contribute to therapy-resistance and reduced survival. Therapies that address the hypoxic microenvironment are therefore likely to significantly improve patient outcomes. Hypoxic regulation of …
-
Effect of protons on the biology of human gliomas
Gliomas are the most common and most deadly primary brain cancer. Patient outcome for the most malignant variety, the World Health Organization (WHO) Type IV glioblastoma multiforme (GBM), has stagnated over the last several decades - the best combination treatment of surgical resection, radiation, …
-
Molecular Characterization of Genetic and Epigenetic Alterations in Gliomas
… of the recurrent genomic alterations in gliomas and further dissect the molecular effects of the most frequently-occurring genomic events. First, we performed a multifaceted genomic analysis to identify genes targeted by copy number alteration in glioblastoma, the most aggressive …
-
Nanocarrier mediated therapies for the gliomas of the brain.
Existing methods of treating glioma are not effective for eradicating the disease. Therefore, new and innovative methods of treatment alone or in combination with existing therapies are necessary. Delivery of therapeutic agents through delivery carriers such as liposomes diminishes the harmful …
-
Mapping the Genesis of Malignant Gliomas at Single-Cell Resolution
Malignant gliomas and glioblastomas are genetically diverse brain malignancies of both children and adults. Despite the remarkable progress in deciphering the genomic architecture of these tumours, the cellular programmes and mechanisms that give rise to the mostly incurable late-stage tumours …
Page 1 of 28